Chen, B. K., Whye, A., Matthews, L. C., Moniz, T., Mendez-David, I., Gardier, A. M., David, D. J., Johns, S., Weisblum, E., & Denny, C. A. (2025). Chronic, combinatorial targeting of NMDARs and 5-HT4Rs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagia. Neuropsychopharmacology. https://doi.org/10.1038/s41386-025-02107-1

Dixon, R., Malave, L., Thompson, R., Wu, S., Li, Y., Sadik, N., & Anacker, C. (2024). Sex-specific and developmental effects of early life adversity on stress reactivity are rescued by postnatal knockdown of 5-HT1A autoreceptors. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01999-9

Olivetti, P. R., Torres-Herraez, A., Gallo, M. E., Raudales, R., Sumerau, M., Moyles, S., Balsam, P. D., & Kellendonk, C. (2024). Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01997-x

Ekhtiari, H., Zare-Bidoky, M., Sangchooli, A., Valyan, A., Abi-Dargham, A., Cannon, D. M., Carter, C. S., Garavan, H., George, T. P., Ghobadi-Azbari, P., Juchem, C., Krystal, J. H., Nichols, T. E., Öngür, D., Pernet, C. R., Poldrack, R. A., Thompson, P. M., & Paulus, M. P. (2024). Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility. Neuropsychopharmacology, 50(1), 67–84. https://doi.org/10.1038/s41386-024-01973-5

Slifstein, M., Qu, W., Gil, R., Weinstein, J. J., Perlman, G., Jaworski-Calara, T., Meng, J., Hu, B., Moeller, S. J., Horga, G., & Abi-Dargham, A. (2024). Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01975-3

Wang, X., Marmouzi, I., Finnie, P. S. B., Bucher, M. L., Yan, Y., Williams, E. Q., Støve, S. I., Lipina, T. V., Ramsey, A. J., Miller, G. W., & Salahpour, A. (2024). Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01914-2

Walsh, S. L., Comer, S. D., Zdovc, J. A., Sarr, C., Björnsson, M., Strandgården, K., Hjelmström, P., & Tiberg, F. (2024). Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder. Neuropsychopharmacology, 49(6), 1050–1057. https://doi.org/10.1038/s41386-023-01793-z

Chen, B. K., Custis, T., Monteggia, L. M., & George, T. P. (2024). Effects of open access publishing on article metrics in Neuropsychopharmacology. Neuropsychopharmacology, 49(4), 757–763. https://doi.org/10.1038/s41386-024-01796-4

Yang, J., Huggins, A. A., Sun, D., Baird, C. L., Haswell, C. C., Frijling, J. L., Olff, M., van Zuiden, M., Koch, S. B. J., Nawijn, L., Veltman, D. J., Suarez-Jimenez, B., Zhu, X., Neria, Y., Hudson, A. R., Mueller, S. C., Baker, J. T., Lebois, L. A. M., Kaufman, M. L., … Sotiras, A. (2023). Examining the association between posttraumatic stress disorder and disruptions in cortical networks identified using data-driven methods. Neuropsychopharmacology, 49(3), 609–619. https://doi.org/10.1038/s41386-023-01763-5

Spann, M. N., Alleyne, K., Holland, C. M., Davids, A., Pierre-Louis, A., Bang, C., Oyeneye, V., Kiflom, R., Shea, E., Cheng, B., Peterson, B. S., Monk, C., & Scheinost, D. (2023). The effects of experience of discrimination and acculturation during pregnancy on the developing offspring brain. Neuropsychopharmacology, 49(2), 476–485. https://doi.org/10.1038/s41386-023-01765-3

Serafini, R. A., Estill, M., Pekarskaya, E. A., Sakloth, F., Shen, L., Javitch, J. A., & Zachariou, V. (2023). Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain. Neuropsychopharmacology, 48(11), 1680–1689. https://doi.org/10.1038/s41386-023-01645-w

Chong, S., & Comer, S. D. (2023). Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Neuropsychopharmacology, 48(12), 1703–1704. https://doi.org/10.1038/s41386-023-01726-w

Tobe, R., Zhu, Y., Gleissl, T., Rossomanno, S., Veenstra-VanderWeele, J., Smith, J., & Hollander, E. (2023). Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder. Neuropsychopharmacology, 48(8), 1201–1216. https://doi.org/10.1038/s41386-023-01573-9

Goetz, T. G., Aghi, K., Anacker, C., Ehrensaft, D., Eshel, N., Marrocco, J., Young, J. W., & Roepke, T. A. (2023). Perspective on equitable translational studies and clinical support for an unbiased inclusion of the LGBTQIA2S+community. Neuropsychopharmacology, 48(6), 852–856. https://doi.org/10.1038/s41386-023-01558-8

De Nadai, A. S., Fitzgerald, K. D., Norman, L. J., Russman Block, S. R., Mannella, K. A., Himle, J. A., & Taylor, S. F. (2022). Defining brain-based OCD patient profiles using task-based fMRI and unsupervised machine learning. Neuropsychopharmacology, 48(2), 402–409. https://doi.org/10.1038/s41386-022-01353-x

ACNP 61st Annual Meeting: Panels, Mini-Panels and Study Groups. (2022). Neuropsychopharmacology, 47(S1), 1–62. https://doi.org/10.1038/s41386-022-01483-2

Han, J., Andreu, V., Langreck, C., Pekarskaya, E. A., Grinnell, S. G., Allain, F., Magalong, V., Pintar, J., Kieffer, B. L., Harris, A. Z., Javitch, J. A., Hen, R., & Nautiyal, K. M. (2021). Mu opioid receptors on hippocampal GABAergic interneurons are critical for the antidepressant effects of tianeptine. Neuropsychopharmacology, 47(7), 1387–1397. https://doi.org/10.1038/s41386-021-01192-2

Schultebraucks, K., Maslahati, T., Wingenfeld, K., Hellmann-Regen, J., Kraft, J., Kownatzki, M., Behnia, B., Ripke, S., Otte, C., & Roepke, S. (2021). Intranasal oxytocin administration impacts the acquisition and consolidation of trauma-associated memories: a double-blind randomized placebo-controlled experimental study in healthy women. Neuropsychopharmacology, 47(5), 1046–1054. https://doi.org/10.1038/s41386-021-01247-4

Sehatpour, P., Javitt, D. C., De Baun, H. M., Carlson, M., Beloborodova, A., Margolin, D. H., Carlton, M. B. L., Brice, N. L., & Kantrowitz, J. T. (2021). Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058. Neuropsychopharmacology, 47(3), 711–718. https://doi.org/10.1038/s41386-021-01170-8

Grossman, Y. S., Fillinger, C., Manganaro, A., Voren, G., Waldman, R., Zou, T., Janssen, W. G., Kenny, P. J., & Dumitriu, D. (2021). Structure and function differences in the prelimbic cortex to basolateral amygdala circuit mediate trait vulnerability in a novel model of acute social defeat stress in male mice. Neuropsychopharmacology, 47(3), 788–799. https://doi.org/10.1038/s41386-021-01229-6

Abraham, E., Wang, Y., Svob, C., Semanek, D., Gameroff, M. J., Shankman, S. A., Weissman, M. M., Talati, A., & Posner, J. (2021). Organization of the social cognition network predicts future depression and interpersonal impairment: a prospective family-based study. Neuropsychopharmacology, 47(2), 531–542. https://doi.org/10.1038/s41386-021-01065-8

Miles, A. E., Dos Santos, F. C., Byrne, E. M., Renteria, M. E., McIntosh, A. M., Adams, M. J., Pistis, G., Castelao, E., Preisig, M., Baune, B. T., Schubert, K. O., Lewis, C. M., Jones, L. A., Jones, I., Uher, R., Smoller, J. W., Perlis, R. H., Levinson, D. F., Potash, J. B., … Nikolova, Y. S. (2021). Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk. Neuropsychopharmacology, 46(13), 2304–2311. https://doi.org/10.1038/s41386-021-01189-x

Chukwueke, C. C., Nona, C. N., McPhee, M. D., Mansouri, E., Rubin-Kahana, D. S., Martinez, D., Boileau, I., Hendershot, C. S., & Le Foll, B. (2021). Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study. Neuropsychopharmacology, 46(12), 2112–2120. https://doi.org/10.1038/s41386-021-01095-2

Chase, H. W., Auerbach, R. P., Brent, D. A., Posner, J., Weissman, M. M., & Talati, A. (2021). Dissociating default mode network resting state markers of suicide from familial risk factors for depression. Neuropsychopharmacology, 46(10), 1830–1838. https://doi.org/10.1038/s41386-021-01022-5

Lori, A., Schultebraucks, K., Galatzer-Levy, I., Daskalakis, N. P., Katrinli, S., Smith, A. K., Myers, A. J., Richholt, R., Huentelman, M., Guffanti, G., Wuchty, S., Gould, F., Harvey, P. D., Nemeroff, C. B., Jovanovic, T., Gerasimov, E. S., Maples-Keller, J. L., Stevens, J. S., Michopoulos, V., … Ressler, K. J. (2021). Transcriptome-wide association study of post-trauma symptom trajectories identified GRIN3B as a potential biomarker for PTSD development. Neuropsychopharmacology, 46(10), 1811–1820. https://doi.org/10.1038/s41386-021-01073-8